Hemochromatosis and iron therapy of Restless Legs Syndrome

Sleep Medicine

Volumn 2, Issue 3, 2001, Pages 249-251

  Barton, James C ^a,d   Wooten, Virgil D ^b   Acton, Ronald T ^c  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Brookwood Medical Center Birmingham   (United States)

Author keywords

Hemochromatosis; Iron; Iron overload; Restless legs syndrome

Indexed keywords

ALPHA TOCOPHEROL; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; FERRITIN; GABAPENTIN; HFE PROTEIN; IRON; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR; TRANSFERRIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHROMOSOME 6; EDEMA; EUROPE; FATIGUE; GASTROINTESTINAL DISEASE; GENE MUTATION; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; INHERITANCE; IRON DEFICIENCY; IRON OVERLOAD; IRON THERAPY; MALE; MEDICAL ASSESSMENT; PHLEBOTOMY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SIBLING; SIDE EFFECT; SYMPTOM; TASTE DISORDER; THORAX PAIN; TREATMENT FAILURE;

EID: 0035745633     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(01)00081-8     Document Type: Article

References (10)

1. Therapy in restless legs
2. Iron status in restless legs syndrome in the elderly
3. The importance of formal iron studies in the assessment of restless legs syndrome
4. Iron and the restless legs syndrome
5. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome
6. A randomized, double-blind, placebo-controlled trial of iron in restless legs syndrome
7. Management of hemochromatosis
8. Hereditary hemochromatosis
9. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
10. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset